Literature DB >> 23292931

COX-2, the dominant source of prostacyclin.

Emanuela Ricciotti, Ying Yu, Tilo Grosser, Garret A Fitzgerald.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23292931      PMCID： PMC3549068          DOI： 10.1073/pnas.1219073110

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  5 in total

1.  Vascular COX-2 modulates blood pressure and thrombosis in mice.

Authors:  Ying Yu; Emanuela Ricciotti; Rosario Scalia; Soon Yew Tang; Gregory Grant; Zhou Yu; Gavin Landesberg; Irene Crichton; Weichen Wu; Ellen Puré; Colin D Funk; Garret A FitzGerald
Journal:  Sci Transl Med       Date:  2012-05-02       Impact factor: 17.956

2.  Cyclooxygenase-1, not cyclooxygenase-2, is responsible for physiological production of prostacyclin in the cardiovascular system.

Authors:  Nicholas S Kirkby; Martina H Lundberg; Louise S Harrington; Philip D M Leadbeater; Ginger L Milne; Claire M F Potter; Malak Al-Yamani; Oladipupo Adeyemi; Timothy D Warner; Jane A Mitchell
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-08       Impact factor: 11.205

3.  Suppression of thromboxane A2 but not of systemic prostacyclin by controlled-release aspirin.

Authors:  R J Clarke; G Mayo; P Price; G A FitzGerald
Journal:  N Engl J Med       Date:  1991-10-17       Impact factor: 91.245

4.  Prostacyclin is not a circulating hormone in man.

Authors:  I A Blair; S E Barrow; K A Waddell; P J Lewis; C T Dollery
Journal:  Prostaglandins       Date:  1982-04

5.  Estimated rate of prostacyclin secretion into the circulation of normal man.

Authors:  G A FitzGerald; A R Brash; P Falardeau; J A Oates
Journal:  J Clin Invest       Date:  1981-11       Impact factor: 14.808
  5 in total
  12 in total

Review 1.  Prostanoids and NSAIDs in cardiovascular biology and disease.

Authors:  Babettte B Weksler
Journal:  Curr Atheroscler Rep       Date:  2015-07       Impact factor: 5.113

2.  Reply to Ricciotti et al.: Evidence for vascular COX isoforms.

Authors:  Jane A Mitchell; Timothy D Warner
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-15       Impact factor: 11.205

Review 3.  The Cardiovascular Pharmacology of Nonsteroidal Anti-Inflammatory Drugs.

Authors:  Tilo Grosser; Emanuela Ricciotti; Garret A FitzGerald
Journal:  Trends Pharmacol Sci       Date:  2017-06-23       Impact factor: 14.819

4.  Dominant Role for Regulatory T Cells in Protecting Females Against Pulmonary Hypertension.

Authors:  Rasa Tamosiuniene; Olga Manouvakhova; Paul Mesange; Toshie Saito; Jin Qian; Mrinmoy Sanyal; Yu-Chun Lin; Linh P Nguyen; Amir Luria; Allen B Tu; Joshua M Sante; Marlene Rabinovitch; Desmond J Fitzgerald; Brian B Graham; Aida Habtezion; Norbert F Voelkel; Laure Aurelian; Mark R Nicolls
Journal:  Circ Res       Date:  2018-03-15       Impact factor: 17.367

5.  Urinary metabolites of prostanoids and risk of recurrent colorectal adenomas in the Aspirin/Folate Polyp Prevention Study (AFPPS).

Authors:  Veronika Fedirko; Patrick T Bradshaw; Jane C Figueiredo; Robert S Sandler; Elizabeth L Barry; Dennis J Ahnen; Ginger L Milne; Robert S Bresalier; John A Baron
Journal:  Cancer Prev Res (Phila)       Date:  2015-08-24

6.  Cyclo-oxygenase-2 inhibition and endothelium-dependent vasodilation in younger vs. older healthy adults.

Authors:  John H Eisenach; Leah R Gullixson; Alexander R Allen; Susan L Kost; Wayne T Nicholson
Journal:  Br J Clin Pharmacol       Date:  2014-10       Impact factor: 4.335

Review 7.  Cardiovascular effects of cyclooxygenase-2 inhibitors: a mechanistic and clinical perspective.

Authors:  Carlo Patrono
Journal:  Br J Clin Pharmacol       Date:  2016-07-18       Impact factor: 4.335

8.  Vasomotor Reaction to Cyclooxygenase-1-Mediated Prostacyclin Synthesis in Carotid Arteries from Two-Kidney-One-Clip Hypertensive Mice.

Authors:  Bin Liu; Zhenhua Li; Yingzhan Zhang; Wenhong Luo; Jiling Zhang; Hui Li; Yingbi Zhou
Journal:  PLoS One       Date:  2015-08-26       Impact factor: 3.240

9.  LC-MS/MS confirms that COX-1 drives vascular prostacyclin whilst gene expression pattern reveals non-vascular sites of COX-2 expression.

Authors:  Nicholas S Kirkby; Anne K Zaiss; Paula Urquhart; Jing Jiao; Philip J Austin; Malak Al-Yamani; Martina H Lundberg; Louise S MacKenzie; Timothy D Warner; Anna Nicolaou; Harvey R Herschman; Jane A Mitchell
Journal:  PLoS One       Date:  2013-07-09       Impact factor: 3.240

10.  Cyclooxygenases 1 and 2 differentially regulate blood pressure and cerebrovascular responses to acute and chronic intermittent hypoxia: implications for sleep apnea.

Authors:  Andrew E Beaudin; Matiram Pun; Christina Yang; David D M Nicholl; Craig D Steinback; Donna M Slater; Katherine E Wynne-Edwards; Patrick J Hanly; Sofia B Ahmed; Marc J Poulin
Journal:  J Am Heart Assoc       Date:  2014-05-09       Impact factor: 5.501
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.